Clinical Trials Directory

Trials / Completed

CompletedNCT05924061

The Role of Pentraxin 3 and Cathepsin B Levels in Preeclamptic Pregnancy

The Role of Pentraxin 3 and Cathepsin B Levels in the Second Trimester in Predicting of Maternal and Fetal Results in Preeclamptic Pregnancy

Status
Completed
Phase
Study type
Observational
Enrollment
156 (actual)
Sponsor
Sanliurfa Mehmet Akif Inan Education and Research Hospital · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

In this study, the investigator aim was to compare Cathepsin B and Pentraxin 3 levels measured from maternal serum of pregnant women diagnosed with preeclampsia in the second trimester, the effects of these levels on maternal/ fetal outcomes and the composite results of Cathepsin B and Pentraxin 3 levels alone or together and contribute to the literature in this area.

Detailed description

This prospective case-control study was conducted between 1 January 2022 and 31 December 2022 at Bursa Yuksek Ihtisas Training and Research Hospital. The study was conducted with pregnant women between ages of 18-45 who were diagnosed with preeclampsia in the second trimester. This study was conducted with total 156 pregnant women. participants were grouped according to the presence of preeclampsia; Group1: Patients diagnosed with preeclampsia between 20-28 weeks (study group) (n:78) , Group 2: Healthy pregnant women between 20-28 weeks without a diagnosis of preeclampsia ( control group) (n:78) . As soon as preeclampsia is diagnosed and before any treatment was started, maternal serum samples were collected in the Cathepsin B and Pentraxin 3 kit in amounts suitable for the study. The samples obtained were kept in biochemistry laboratory at -80 degrees until the study was conducted. After all samples were collected, Cathepsin B and Pentraxin 3 values were measured by ELISA method.

Conditions

Interventions

TypeNameDescription
OTHERCathepsin B and pentraxin 3 levels in preeclampsia with pregnant womenThe effect of cathepsin b and pentraxin 3 levels on maternal/fetal outcomes in pregnant women diagnosed with preeclampsia

Timeline

Start date
2022-01-01
Primary completion
2022-12-31
Completion
2022-12-31
First posted
2023-06-29
Last updated
2023-06-29

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT05924061. Inclusion in this directory is not an endorsement.

The Role of Pentraxin 3 and Cathepsin B Levels in Preeclamptic Pregnancy (NCT05924061) · Clinical Trials Directory